Selected Research Faculty
Jonathan E. Alpert MD, PhD
Novel treatments for mood disorders; depressive subtypes; research ethics and design; medical education
Julia Arnstein, MD
Behavioral medicine including adherence to medication-taking, nicotine dependence, and substance abuse; addiction with comorbid chronic medical illness
Anita Autry PhD
Understanding neural circuits that control social behavior and how these circuits are regulated under physiological and pathological conditions
Laurie J. Bauman, PhD
HIV prevention; adolescent sexual behavior/pregnancy; adolescent mental health; chronic illness in children and adolescents; adherence; research methods (randomized trials, qualitative research and mixed methods); Community-based participatory research.
Benjamin Le Cook, Ph.D.
Improving methods for measuring disparities, and applying these methods to understanding the mechanisms underlying mental health and substance abuse treatment disparities, the association between acculturation and mental health, geographic differences in mental health service use disparities.
Pablo Castillo MD, PhD
Excitatory and inhibitory synaptic transmission and plasticity under physiological and brain disease conditions such as Alzheimer’s disease, epilepsy, autism, schizophrenia and drug abuse
Mirnova E. Ceide, MD
Understanding cognitive and motor function in older adults; dementia; geriatric psychiatry
Henry Chung, MD
Behavioral health integration
Chinazo Cunningham, MD, MS
Access to care and health outcomes among drug users with or at-risk for HIV; buprenorphine treatment in primary care settings; opioid use, misuse, and addiction; collaborating with community-based organizations
Emad N. Eskandar, MD
Developing novel neurosurgical and neuromodulatory approaches for neuropsychiatric conditions
Vilma Gabbay, MD
Damara Gutnick MD
Community based participatory research, opioid use disorders, addressing clinician burnout, improving patient experience
Noboru Hiroi, PhD
Genetic bases of nicotine dependence, 22q11 syndrome, and other neuropsychiatric conditions
Eric Hollander, MD
Novel treatments including CBDV in Autism Spectrum Disorder (ASD); oxytocin in Prader Willi Syndrome (PWS); vasopressin 1a antagonists in ASD; alpha-1 chemotrypsin in ASD; Intermittent Explosive Disorder; Tourette Syndrome; transcranial magnetic stimulation (TMS) in OCD and ASD
Bryen A. Jordan, PhD
Synaptic plasticity; RNA transport and local translation in neurons; synapse-to-nucleus signaling; proteomic analysis of the dynamics of synaptic junctions; molecular mechanisms underlying neuropsychiatric disorders.
Kamran Khodakhah, PhD
Cerebellar physiology and function; cerebellar contributions to motor coordination and movement disorders as well as to other disorders including Autism, schizophrenia, addiction and migraine.
Herbert M. Lachman, MD
Induced pluripotent stem cell technology to study the molecular basis of schizophrenia and autism by RNA-seq and ChIP-seq; patient-specific lines and isogenic knockout lines, generated by CRISP-Cas9.
Richard Lipton, MD
Longitudinal population studies that link stress, pain and cognitive performance to genetics, biomarkers and neuroimaging
Michael L. Lipton, MD, PhD
Neuroimaging; Traumatic Brain Injury (TBI); concussion injury; image processing and analysis, diffusion imaging; white matter microstructure; cognitive dysfunction
Alain Litwin, MD
Models of hepatitis C virus (HCV) care for drug users; access to effective care for HCV-infected patients.
Allissa Mallow DSW
Behavioral health integration, substance use disorders, work force diversity.
Mark Mehler, MD
Stem Cell Biology and Regenerative Medicine; Epigenetics and Evolutionary Biology; Developmental Pathogenesis of Neurodegenerative Diseases; Cytokine Biology/Signal Transduction Pathways in Neurodevelopmental Disorders (Autism/ASD)
Sophie Molholm, PhD
Neurobiology of development disorders, particularly autism, with focus on how the human brain processes and integrates sensory inputs to impact perception and behavior, and the role of attention.
Wenzhu Mowrey, PhD
Biostatistical approaches and study design in neuropsychiatric and neuroimaging research
Anne Murphy, PhD
Parent-child treatment for parents with a history of abuse or neglect; creating positive social emotional and developmental outcomes for offspring of parents with trauma histories.
Shadi Nahvi, MD, MS
Interventions to treat tobacco use among opiate dependent patients in methadone maintenance treatment, and among other vulnerable populations
Saleem M. Nicola, PhD
Electrophysiological, behavioral and pharmacological approaches to studying neural circuits underlying reward-seeking and addictive behaviors.
-powell.jpg)
Patricia (Tia) Powell, MD
Bioethics issues in public policy, dementia, mediation/consultation, end of life care, bioethics education and public health disasters.
Jelena Radulovic, MD, PhD
Caryn R. R. Rodgers, PhD
Protective and risk factors for adolescent problem behaviors and the conceptualization of resilience in urban, low-income communities, particularly among youth of color.
Rachel Ross, MD, PhD
Stephanie Rudolph, PhD
Gary J. Schwartz, Ph.D.
Studying gut-brain communication in the regulation of food intake and associated metabolic processes; identifying therapeutic targets for eating behaviors associated with obesity, diabetes, and related diseases.
Lucas Sjulson, MD, PhD
Understanding dysregulation of frontolimbic circuits in drug addiction-related behaviors; Developing and validating new technologies and targets for gene-based clinical neuromodulation.
